Working… Menu

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00337389
Recruitment Status : Unknown
Verified November 2007 by Mast Therapeutics, Inc..
Recruitment status was:  Active, not recruiting
First Posted : June 16, 2006
Last Update Posted : November 19, 2007
Information provided by:
Mast Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Primary Completion Date : No date given
Study Completion Date : No date given